Ticker
ADMP

Price
0.12
Stock movement up
+0.02 (14.61%)
Company name
Adamis Pharma
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers-Specialty & Generic
Market cap
18.00M
Ent value
24.87M
Price/Sales
11.68
Price/Book
6.33
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-81.25%
3 year return
-29.75%
5 year return
-48.84%
10 year return
-35.76%
Last updated: 2023-03-22
Adamis Pharmaceuticals Corporation (NASDAQ:NASDAQ:ADMP) Q4 2022 Results Conference Call March 16, 2023 5:00 PM ETCompany ParticipantsRobert Uhl - MD, ICR WestwickeDavid Marguglio - CEODavid...
March 17, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
March 16, 2023

iO Charts is a Seeking Alpha partner

DIVIDENDS

ADMP does not pay dividends or no data was received
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
March 14, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
February 23, 2023

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales11.68
Price to Book6.33
EV to Sales16.14
Adamis Pharmaceuticals Corporation (NASDAQ:NASDAQ:ADMP) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ETCompany ParticipantsRobert Uhl - Westwicke PartnersDavid Marguglio -...
November 15, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
November 14, 2022

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count149.98M
EPS (TTM)-0.21
FCF per share (TTM)-0.21

Income statement

Loading...
Income statement data
Revenue (TTM)1.54M
Gross profit (TTM)-4.25M
Operating income (TTM)-28.63M
Net income (TTM)-31.92M
EPS (TTM)-0.21
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-276.18%
Operating margin (TTM)-1858.60%
Profit margin (TTM)-2072.23%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.42M
Net receivables1.55M
Total current assets10.09M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets12.14M
Accounts payable5.30M
Short/Current long term debt432.02K
Total current liabilities8.87M
Total liabilities9.29M
Shareholder's equity2.85M
Net tangible assets2.85M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-31.05M
Capital expenditures (TTM)816.10K
Free cash flow (TTM)-31.84M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-1121.97%
Return on Assets-263.03%
Return on Invested Capital-993.24%
Cash Return on Invested Capital-990.63%
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
October 3, 2022

iO Charts is a Seeking Alpha partner

Adamis has a long track record of fumbles and failures. I'm finally ready to put ADMP on my “Wall of Shame” and ultimately mothball the position. Read more here.
September 30, 2022

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.10
Daily high0.13
Daily low0.10
Daily Volume1.51M
All-time high1835.63
1y analyst estimate0.42
Beta1.29
EPS (TTM)-0.21
Dividend per share-
Ex-div date-
Next earnings date15 May 2023

Downside potential

Loading...
Downside potential data
ADMPS&P500
Current price drop from All-time high-99.99%-17.92%
Highest price drop-99.99%-56.47%
Date of highest drop20 Mar 20239 Mar 2009
Avg drop from high-80.35%-11.51%
Avg time to new high253 days13 days
Max time to new high5749 days1805 days
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
September 21, 2022

iO Charts is a Seeking Alpha partner

Adamis Pharmaceuticals Corporation (NASDAQ:NASDAQ:ADMP) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ETCompany ParticipantsRobert Uhl - Managing Director, ICR WestwickeDavid J.
August 11, 2022

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ADMP (Adamis Pharma) company logo
Marketcap
18.00M
Marketcap category
Small-cap
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
Employees
15
Investor relations
-
SEC filings
CEO
Dennis J. Carlo
Country
USA
City
San Diego
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
August 10, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
July 29, 2022

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
July 21, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
May 18, 2022

iO Charts is a Seeking Alpha partner

COMPANY NEWS
All newsPress releases
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q4 2022 Earnings Call Transcript March 17, 2023 Operator: Greetings, and welcome to the Adamis Pharmaceuticals Full Year 2022 Financial Results Confere...
March 20, 2023
Q4 2022 Adamis Pharmaceuticals Corp Earnings Call
March 17, 2023
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ETSAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company fo...
March 16, 2023
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing produc...
March 14, 2023
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing produc...
March 14, 2023
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) and DMK Pharmaceuticals Corp entered into an Agreement and Plan of Merger and Reorganization. DMK Pharmaceuticals is a privately held, clinical-stage ...
February 28, 2023
Combined company will have commercial products and a library of development candidates, two of which are clinical stageWill be under the leadership of DMK CEO, Dr. Ebrahim (Eboo) Versi MD, PhDLead dev...
February 27, 2023
SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing product...
February 22, 2023
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q3 2022 Earnings Call Transcript November 14, 2022 Operator: Good afternoon, ladies and gentlemen, and welcome to the Adamis Pharmaceuticals’ Third Qua...
December 29, 2022
Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ETSAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopha...
November 14, 2022
Next page
Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha.
May 17, 2022

iO Charts is a Seeking Alpha partner

Adamis Pharmaceuticals Corporation (NASDAQ:NASDAQ:ADMP) Q1 2022 Earnings Conference Call May 16, 2022 5:00 PM ETCorporate ParticipantsRobert Uhl - ICR WestwickeDennis Carlo - President and...
May 17, 2022

iO Charts is a Seeking Alpha partner